Hemophilia B

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA
FDA
FDA Approves Pediatric Treatment for Hereditary Angioedema
07/20/2016
The FDA has approved a treatment for hereditary angioedema attacks in pediatric patients.
07/20/2016
FDA Alerts
FDA Alerts
FDA Approves New Weight Loss Drug Formulation
07/19/2016
The FDA has approved a new formulation for lorcaserin HCI for the management of weight in adults.
07/19/2016
FDA Alerts
FDA Alerts
FDA Approves New Weight Loss Drug Formulation
07/19/2016
The FDA has approved a new formulation for lorcaserin HCI for the management of weight in adults.
07/19/2016
FDA Alerts
FDA Alerts
FDA Approves New Weight Loss Drug Formulation
07/19/2016
The FDA has approved a new formulation for lorcaserin HCI for the management of weight in adults.
07/19/2016
FDA Alerts
FDA Alerts
FDA Approves 2016-2017 Influenza Vaccine Formulation
07/13/2016
The FDA has approved the 2016-2017 formulation of Flublok—an egg-free, protein-based vaccine—for prevention of seasonal influenza.
07/13/2016
FDA Alerts
FDA Alerts
FDA Approves 2016-2017 Influenza Vaccine Formulation
07/13/2016
The FDA has approved the 2016-2017 formulation of Flublok—an egg-free, protein-based vaccine—for prevention of seasonal influenza.
07/13/2016
FDA Alerts
FDA Alerts
FDA Approves 2016-2017 Influenza Vaccine Formulation
07/13/2016
The FDA has approved the 2016-2017 formulation of Flublok—an egg-free, protein-based vaccine—for prevention of seasonal influenza.
07/13/2016
FDA Alerts
FDA Alerts
FDA seeks more data on over-the-counter hand sanitizers
06/29/2016
...
06/29/2016
FDA Alerts
FDA Alerts
FDA Approves New Hep C Treatment
06/28/2016
The FDA approved Epclusa (fixed-dose combination of sofosbuvir and velpatasvir) to treat adult patients with chronic hepatitis C virus with and without cirrhosis.
06/28/2016
FDA Alerts
FDA Alerts
FDA Approves New Hep C Treatment
06/28/2016
The FDA approved Epclusa (fixed-dose combination of sofosbuvir and velpatasvir) to treat adult patients with chronic hepatitis C virus with and without cirrhosis.
06/28/2016